88 related articles for article (PubMed ID: 19564097)
41. Early prediction of antipsychotic nonresponse among patients with schizophrenia.
Leucht S; Busch R; Kissling W; Kane JM
J Clin Psychiatry; 2007 Mar; 68(3):352-60. PubMed ID: 17388703
[TBL] [Abstract][Full Text] [Related]
42. Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study.
Kane JM; Yang R; Youakim JM
Schizophr Res; 2012 Mar; 135(1-3):116-22. PubMed ID: 22178084
[TBL] [Abstract][Full Text] [Related]
43. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Olié JP; Spina E; Murray S; Yang R
Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
[TBL] [Abstract][Full Text] [Related]
44. Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia.
Ogyu K; Noda Y; Yoshida K; Kurose S; Masuda F; Mimura Y; Nishida H; Plitman E; Tarumi R; Tsugawa S; Wada M; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
Neuropsychopharmacol Rep; 2020 Jun; 40(2):138-149. PubMed ID: 32180369
[TBL] [Abstract][Full Text] [Related]
45. Early prediction of clinical response in first episode schizophrenia (FES) patients receiving olanzapine.
Subeesh V; Maheswari E; Singh H; Saraswathy GR; Reddy N; Chiranjeevi P
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):309-314. PubMed ID: 32338556
[No Abstract] [Full Text] [Related]
46. Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study.
Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Degner D; Buchkremer G; Gastpar M; Möller HJ; Riedel M
Eur Psychiatry; 2009 Dec; 24(8):501-6. PubMed ID: 19559572
[TBL] [Abstract][Full Text] [Related]
47. Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
Lin CH; Lin HS; Lin SC; Kuo CC; Wang FC; Huang YH
Acta Psychiatr Scand; 2018 Feb; 137(2):98-108. PubMed ID: 29280500
[TBL] [Abstract][Full Text] [Related]
48. Antipsychotic treatment response in schizophrenia.
Gardner KN; Bostwick JR
Am J Health Syst Pharm; 2012 Nov; 69(21):1872-9. PubMed ID: 23111671
[TBL] [Abstract][Full Text] [Related]
49. Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia.
Xiao W; Zhan Q; Ye F; Tang X; Li J; Dong H; Sha W; Zhang X
Eur Neuropsychopharmacol; 2018 May; 28(5):603-609. PubMed ID: 29602597
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.
Iasevoli F; Avagliano C; Altavilla B; Barone A; Ciccarelli M; D'Ambrosio L; Notar Francesco D; Razzino E; Fornaro M; de Bartolomeis A
Psychiatry Res; 2018 Nov; 269():481-493. PubMed ID: 30195742
[TBL] [Abstract][Full Text] [Related]
51. Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Schennach-Wolff R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Engel RR; Möller HJ; Riedel M
J Clin Psychopharmacol; 2010 Dec; 30(6):726-31. PubMed ID: 21105273
[TBL] [Abstract][Full Text] [Related]
52. A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic Patients.
Pérez-Ruixo C; Remmerie B; Peréz-Ruixo JJ; Vermeulen A
AAPS J; 2019 Mar; 21(3):40. PubMed ID: 30874997
[TBL] [Abstract][Full Text] [Related]
53. Refining Clinical Judgment of Treatment Response and Symptom Remission Identification in Childhood Anxiety Using a Signal Detection Analysis on the Pediatric Anxiety Rating Scale.
Johnco CJ; Salloum A; Lewin AB; Storch EA
J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):674-83. PubMed ID: 26579629
[TBL] [Abstract][Full Text] [Related]
54. A systematic method for estimating individual responses to treatment with antipsychotics in CATIE.
van den Oord EJ; Adkins DE; McClay J; Lieberman J; Sullivan PF
Schizophr Res; 2009 Jan; 107(1):13-21. PubMed ID: 18930379
[TBL] [Abstract][Full Text] [Related]
55. Assessing the severity of psychiatric disorders using the Health of the Nation Outcome Scales: An equipercentile linking analysis.
Egger ST; Bobes J; Theodoridou A; Seifritz E; Vetter S
Aust N Z J Psychiatry; 2020 Dec; 54(12):1192-1199. PubMed ID: 33032447
[TBL] [Abstract][Full Text] [Related]
56. A Clinical Study Protocol to Identify Serum Biomarkers Predictive of Response to Antipsychotics in Schizophrenia Patients.
Steiner J; Guest PC
Adv Exp Med Biol; 2017; 974():245-250. PubMed ID: 28353242
[TBL] [Abstract][Full Text] [Related]
57. A symptom combination predicting treatment-resistant schizophrenia - A strategy for real-world clinical practice.
Ortiz BB; Higuchi CH; Noto C; Joyce DW; Correll CU; Bressan RA; Gadelha A
Schizophr Res; 2020 Apr; 218():195-200. PubMed ID: 31956005
[TBL] [Abstract][Full Text] [Related]
58. When should clinicians switch treatments? An application of signal detection theory to two treatments for women with alcohol use disorders.
Hildebrandt T; McCrady B; Epstein E; Cook S; Jensen N
Behav Res Ther; 2010 Jun; 48(6):524-30. PubMed ID: 20359693
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D Levels in Different Severity Groups of Schizophrenia.
Akinlade KS; Olaniyan OA; Lasebikan VO; Rahamon SK
Front Psychiatry; 2017; 8():105. PubMed ID: 28659835
[TBL] [Abstract][Full Text] [Related]
60. Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
Long Y; Wu Q; Yang Y; Cai J; Xiao J; Liu Z; Xu Y; Chen Y; Huang M; Zhang R; Xu X; Hu J; Liu Z; Liu F; Zheng Y; Meng H; Wang Z; Tang Y; Song X; Chen Y; Wang X; Liu T; Wu X; Fang M; Wan C; Zhao J; Wu R
BMC Med; 2023 Jul; 21(1):263. PubMed ID: 37468932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
